Literature DB >> 2454938

Immune response to Escherichia coli alpha-hemolysin in patients.

S Seetharama1, S J Cavalieri, I S Snyder.   

Abstract

The serum antibody response of patients infected with alpha-hemolysin (AH)-producing Escherichia coli was measured by three immunoassays: tube neutralization, microneutralization, and enzyme-linked immunosorbent assay. All three assay results showed good correlation with each other. The mean anti-AH titer in patients with E. coli infection was higher than the mean titer in noninfected patients. The hemolysin-neutralizing activity was immunoglobulin G. The amount of lipopolysaccharide (LPS) antibody did not correlate with the amount of AH antibody. LPS antibody measured by enzyme-linked immunosorbent assay was predominantly of the immunoglobulin G class. Adsorption of LPS antibody by E. coli H79 LPS did not affect anti-AH titers, indicating that LPS and AH have different antigenic determinants. AHs prepared from several different E. coli strains had identical or similar antigenic determinants at the active site. Hemolysin proteins separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis were stained identically by human sera with AH antibody and by a mouse monoclonal AH antibody.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2454938      PMCID: PMC266473          DOI: 10.1128/jcm.26.5.850-856.1988

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  23 in total

1.  Properties of strains of Escherichia coli isolated from a variety of sources.

Authors:  E M Cooke; S P Ewins
Journal:  J Med Microbiol       Date:  1975-02       Impact factor: 2.472

2.  The haemolysins of Escherichia coli.

Authors:  H W SMITH
Journal:  J Pathol Bacteriol       Date:  1963-01

3.  Pathogenesis of pyelonephritis. Escherichia coli-induced renal ultrastructural changes.

Authors:  T L Fry; F A Fried; B A Goven
Journal:  Invest Urol       Date:  1975-07

4.  Etiology of pyelonephritis: further evidence associating the production of experimental pyelonephritis with hemolysis in Escherichia coli.

Authors:  F A Fried; C W Vermeulen; M J Ginsburg; C M Cone
Journal:  J Urol       Date:  1971-09       Impact factor: 7.450

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Antibody response to the lipopolysaccharide and protein antigens of Salmonella typhi during typhoid infection. I. Measurement of serum antibodies by radioimmunoassay.

Authors:  R S Tsang; P Y Chau; S K Lam; J T La Brooy; D Rowley
Journal:  Clin Exp Immunol       Date:  1981-12       Impact factor: 4.330

7.  Production and characteristics of hemolysins of Escherichia coli.

Authors:  I S Snyder; N A Koch
Journal:  J Bacteriol       Date:  1966-02       Impact factor: 3.490

8.  Isolation of a lipopolysaccharide mutant of Neisseria gonorrhoeae: an analysis of the antigenic and biologic difference.

Authors:  S A Morse; M A Apicella
Journal:  J Infect Dis       Date:  1982-02       Impact factor: 5.226

9.  Hemolysin and K antigens in relation to serotype and hemagglutination type of Escherichia coli isolated from extraintestinal infections.

Authors:  D J Evans; D G Evans; C Höhne; M A Noble; E V Haldane; H Lior; L S Young
Journal:  J Clin Microbiol       Date:  1981-01       Impact factor: 5.948

10.  Virulence of Escherichia coli in experimental hematogenous pyelonephritis in mice.

Authors:  J F van den Bosch; J de Graaff; D M MacLaren
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

View more
  7 in total

1.  The type II secretion system is essential for erythrocyte lysis and gut colonization by the leech digestive tract symbiont Aeromonas veronii.

Authors:  Michele Maltz; Joerg Graf
Journal:  Appl Environ Microbiol       Date:  2010-11-19       Impact factor: 4.792

2.  Quantitative study of the binding and hemolytic efficiency of Escherichia coli hemolysin.

Authors:  B Eberspächer; F Hugo; S Bhakdi
Journal:  Infect Immun       Date:  1989-03       Impact factor: 3.441

3.  Alpha-hemolysin contributes to the pathogenicity of piliated digalactoside-binding Escherichia coli in the kidney: efficacy of an alpha-hemolysin vaccine in preventing renal injury in the BALB/c mouse model of pyelonephritis.

Authors:  P O'Hanley; G Lalonde; G Ji
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

4.  Epitopes of Escherichia coli alpha-hemolysin: identification of monoclonal antibodies that prevent hemolysis.

Authors:  G E Ji; P O'Hanley
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

Review 5.  Virulence factors in Escherichia coli urinary tract infection.

Authors:  J R Johnson
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132

6.  Genetic conservation of hlyA determinants and serological conservation of HlyA: basis for developing a broadly cross-reactive subunit Escherichia coli alpha-hemolysin vaccine.

Authors:  P O'Hanley; R Marcus; K H Baek; K Denich; G E Ji
Journal:  Infect Immun       Date:  1993-03       Impact factor: 3.441

7.  Hemolysin of uropathogenic Escherichia coli evokes extensive shedding of the uroepithelium and hemorrhage in bladder tissue within the first 24 hours after intraurethral inoculation of mice.

Authors:  Yarery C Smith; Susan B Rasmussen; Kerian K Grande; Richard M Conran; Alison D O'Brien
Journal:  Infect Immun       Date:  2008-04-28       Impact factor: 3.441

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.